Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beeh, K. M.
Right arrow Articles by Buhl, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beeh, K. M.
Right arrow Articles by Buhl, R.
(Chest. 2004;126:1116-1122.)
© 2004 American College of Chest Physicians

Increased Glutathione Disulfide and Nitrosothiols in Sputum Supernatant of Patients With Stable COPD*

Kai Michael Beeh, MD; Jutta Beier, MD; Nicole Koppenhoefer and Roland Buhl, MD, PhD

* From the Pulmonary Department, Internal Medicine, University Hospital Mainz, Germany.

Correspondence to: Kai Michael Beeh, MD, Pulmonary Department, Internal Medicine, University Hospital, Langenbeckstr. 1, 55131 Mainz, Germany; e-mail: k.beeh{at}3-med.klinik.uni-mainz.de

Study objectives: Increased oxidant burden is involved in the pathogenesis of COPD. Glutathione (GSH) is a major antioxidant scavenging reactive oxygen and nitrogen species. We studied the concentrations of total and reduced GSH, glutathione disulfide (GSSG), and nitrosothiols in sputum supernatant of patients with COPD.

Design: Twenty-five patients with moderate-to-severe COPD (FEV1 61 ± 12% of predicted) and 25 healthy nonsmoking control subjects underwent sputum induction. Sputum total GSH and GSSG were measured spectrophotometrically, and nitrosothiols were quantified by enzyme assay. Exhaled nitric oxide (eNO) was also measured to correlate eNO with nitrosothiols in induced sputum.

Measurements and results: Compared with healthy subjects, patients with COPD had increased sputum neutrophils (geometric mean, 65%; 95% confidence interval [CI], 57.5 to 71; vs 21%; 95% CI, 13.2 to 31.6; p < 0.001); total GSH (geometric mean, 7.1 µmol/L; 95% CI, 2.95 to 17; vs 5.1 µmol/L; 95% CI, 3.2 to 8.1; p = 0.024); GSSG (geometric mean, 4.1 µmol/L; 95% CI, 1.7 to 10; vs 0.84 µmol/L; 95% CI, 0.35 to 1.99; p = 0.002); and nitrosothiols (geometric mean, 60.4 µmol/L; 95% CI, 40 to 95.5; vs 38 µmol/L; 95% CI, 31.6 to 43.6; p = 0.04). Sputum GSSG was positively correlated with neutrophils ({rho} = 0.47, p = 0.016) and nitrosothiols ({rho} = 0.49, p = 0.024) in patients with COPD, whereas there was no correlation of eNO with nitrosothiols ({rho} = 0.38, p = 0.1).

Conclusions: Sputum concentrations of GSSG and nitrosothiols are increased in patients with COPD and associated with neutrophilic inflammation. These data underline the role of oxidative stress in the pathogenesis of COPD, and suggest that GSH is important to scavenge both reactive oxygen and nitrogen species.

Key Words: antioxidants • COPD • glutathione • induced sputum • neutrophils • nitrosothiols






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.